These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 33952454)
1. Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors. Obata T; Shiratani S; Nada T; Kasaya Y; Arisawa M; Shuto S; Tanaka M Anticancer Res; 2021 May; 41(5):2287-2296. PubMed ID: 33952454 [TBL] [Abstract][Full Text] [Related]
2. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299 [TBL] [Abstract][Full Text] [Related]
3. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1). Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887 [TBL] [Abstract][Full Text] [Related]
4. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors. Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925 [TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions. Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors. Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors. Cui G; Lai F; Wang X; Chen X; Xu B Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase. Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733 [TBL] [Abstract][Full Text] [Related]
10. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors. Gao D; Li Y Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475 [TBL] [Abstract][Full Text] [Related]
11. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening. Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors. Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of flavonoids isolated from Kwon M; Ko SK; Jang M; Kim GH; Ryoo IJ; Son S; Ryu HW; Oh SR; Lee WK; Kim BY; Jang JH; Ahn JS J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1481-1488. PubMed ID: 31423846 [TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents. Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function. Yan D; Xu J; Tan X Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors. Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO). Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors. Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748 [TBL] [Abstract][Full Text] [Related]
19. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1. Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006 [TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO). Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]